š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
To determine the maximum tolerated dose, safety, pharmacokinetics and anti-...
Status
Completed
Location
1200.69.3301 Boehringer Ingelheim Investigational Site
Start Date
2009-06
Trial ID
NCT00906698
Study to determine the maximum tolerated dose of BIBW 2992 when combined wi...
Status
Completed
Location
1200.37.3202 Boehringer Ingelheim Investigational Site
Start Date
2008-07-01
Trial ID
NCT00716417
The objective of the Phase I step is to estimate the MTD at a dose level up...
Status
Completed
Location
1200.33.010 Boehringer Ingelheim Investigational Site
Start Date
2008-04
Trial ID
NCT00711594
Treatments Being Tested
Despite recent advances, the prognosis of patients with advanced gastric ca...
Status
Recruiting
Location
Samsung Medical Center
Start Date
2024-09-30
Trial ID
NCT06085755
Treatments Being Tested
* To identify the Maximum Tolerated Dose (MTD) of afatinib in combination w...
Status
Completed
Location
1200.84.003 Boehringer Ingelheim Investigational Site
Start Date
2010-10-01
Trial ID
NCT01214616
Treatments Being Tested
Study to determine the Maximum Tolerated dose of BIBW 2992 given in combina...
Status
Completed
Location
1200.68.44001 Boehringer Ingelheim Investigational Site
Start Date
2009-08-01
Trial ID
NCT00950742
Treatments Being Tested